Becton, Dickinson and Co. | BDX - Marktkapitalisierung

Aktienkurs
144.43
Täglich Wechseln
-2.52 -1.71%
Monatlich
-7.21%
Jährlich
-16.18%
Q2 Prognose
140.59




Marktkapitalisierung Veränderung Datum
Abbott USD 178.41B 39.46B 2026-03
Agilent USD 37.86B 3.64B 2025-12
Align Technology USD 12.28B 1.07B 2026-03
AngioDynamics USD 511M 94M 2025-09
Avanos Medical USD 1.14B 491M 2026-05
Baxter International USD 8.67B 1.15B 2026-03
Becton, Dickinson and Co. USD 44.45B 323M 2026-05
Boston Scientific USD 93.26B 48.09B 2026-03
Cooper Companies USD 15.95B 2.05B 2025-12
Danaher USD 128.46B 33.24B 2026-03
Dentsply International USD 2.28B 36M 2026-05
Dexcom USD 24.17B 1.72B 2026-03
Edwards Lifesciences USD 46.17B 3.3B 2026-03
Globus Medical USD 11.52B 172M 2026-05
Insulet USD 10.58B 3.96B 2026-05
Integra LifeSciences USD 1.04B 306M 2026-05
Intuitive Surgical USD 163.73B 37.04B 2026-03
J&J USD 579.15B 78.91B 2026-03
Masimo USD 9.46B 108M 2026-05
Stryker USD 125.85B 8.57B 2026-03
Tandem Diabetes Care USD 1.21B 278M 2026-05
Teleflex USD 6.2B 901M 2026-05
Terumo JPY 3.36T 240.28B 2026-05
Thermo Fisher Scientific USD 182.66B 35.04B 2026-03
WK Kellogg Co USD 12.68B 1.35B 2026-05
Zimmer Biomet Holdings USD 17.5B 321M 2026-03